Literature DB >> 11316487

Transport of bile acids in hepatic and non-hepatic tissues.

M V St-Pierre1, G A Kullak-Ublick, B Hagenbuch, P J Meier.   

Abstract

Bile acids are steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. Individual bile acid carriers have now been cloned from several species. Na+-dependent transporters that mediate uptake into hepatocytes and reabsorption from the intestine and biliary epithelium and an ATP-dependent transporter that pumps bile acids into bile comprise the classes of transporter that are specific for bile acids. In addition, at least four human and five rat genes that code for Na+-independent organic anion carriers with broad multi-substrate specificities that include bile acids have been discovered. Studies concerning the regulation of these carriers have permitted identification of molecular signals that dictate eventual changes in the uptake or excretion of bile acids, which in turn have profound physiological implications. This overview summarizes and compares all known bile acid transporters and highlights findings that have identified diseases linked to molecular defects in these carriers. Recent advances that have fostered a more complete appreciation for the elaborate disposition of bile acids in humans are emphasized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316487     DOI: 10.1242/jeb.204.10.1673

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  40 in total

1.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

Review 2.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

3.  Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy.

Authors:  Valgardur Sigurdsson; Youichi Haga; Hajime Takei; Els Mansell; Chizuko Okamatsu-Haga; Mitsuyoshi Suzuki; Visnja Radulovic; Mark van der Garde; Shuhei Koide; Svetlana Soboleva; Mats Gåfvels; Hiroshi Nittono; Akira Ohara; Kenichi Miharada
Journal:  Blood Adv       Date:  2020-05-12

4.  Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

Authors:  Pablo M González; Carlos F Lagos; Weslyn C Ward; James E Polli
Journal:  Mol Pharm       Date:  2013-12-26       Impact factor: 4.939

5.  Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).

Authors:  Anand Balakrishnan; Daniel J Sussman; James E Polli
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

6.  Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability.

Authors:  Richard H Ho; Brenda F Leake; Dawn M Kilkenny; Henriette E Meyer Zu Schwabedissen; Hartmut Glaeser; Deanna L Kroetz; Richard B Kim
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

Review 7.  The sodium bile salt cotransport family SLC10.

Authors:  Bruno Hagenbuch; Paul Dawson
Journal:  Pflugers Arch       Date:  2003-07-08       Impact factor: 3.657

Review 8.  Bile acids: emerging role in management of liver diseases.

Authors:  Amon Asgharpour; Divya Kumar; Arun Sanyal
Journal:  Hepatol Int       Date:  2015-08-29       Impact factor: 6.047

9.  Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.

Authors:  Pablo M González; Chayan Acharya; Alexander D Mackerell; James E Polli
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

10.  Gallbladder motility in patients with hepatic cirrhosis before and after portal azygous disconnection.

Authors:  Hong-Xu Jin; Shuo-Dong Wu; Xue-Feng Zhang; Xian-Ying Chen; Guo-Xu Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.